US & China "enhanced mutual understanding"
This article was originally published in Clinica
Executive Summary
Trade concerns and medtech regulatory knowledge-sharing were key agenda items at a China-US meeting hosted by the Chinese State Food and Drug Administration (SFDA) on April 18-19. The China Association for Medical Devices Industry (CAMDI) praised the meeting, in Guilin, Guangxi province as having "enhanced mutual understanding" between Chinese and US regulatory authorities and business communities.